Reading KWR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KWR free→Reading KWR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KWR free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-06-12
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral, and earnings quality is robust, cash backs up reported profits. Management's recent track record has been fairly steady, while risk is elevated and the sector backdrop is a headwind. Peer multiples imply a price roughly in line with where it trades (about fair); the read is fair, but weakening. If KWR cuts guidance on the next call, that could be a meaningful negative. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $144.46. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $144 KWR trades at 20× p/e, in line with its 20× p/e peer median. Our $147 fair value reflects that, high confidence. Analysts: $151–$203. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 2% below a flat-multiple fair value, in line with our forecast of about 5%. This describes what's priced in, not a forecast of the move.
No fragility gates fired. Regime (Crisis) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 57% for the rest of the cohort, n=1462).
Over the trailing year it converted 33.64x of net income into operating cash flow. Historically, Materials names rated robust grew net income 64% of the time over the next year (vs 49% for the rest of the cohort, n=988).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.58 → $1.62 (+2.4% / 30d). 0 raised, 4 cut, 7 covering analysts.
0 upgrades, 0 downgrades / 30d. 100% of analysts rate Buy.
1 PT revisions / 30d. Avg target 22.3% above current price.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$125.
How much price usually moves either way.
On a bad day, this stock has moved -$381.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,646.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Company momentum rose by 30.9 points (from -17.5 to 13.4).
Confidence changed from 'medium' to 'high'.
Signal changed from 'mixed' to 'mild_favorable'.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Success in Asia/Pacific can help overall revenue growth. It may also balance weak markets.
Confirms:New business wins in Asia/Pacific exceed 10% growth year over year.
Disproves:New business wins in Asia/Pacific fall below 4% growth year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for KWR yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Chairman of the Board — Michael F. Barry: Mr. Michael F. Barry retired from the Board and was succeeded by Mr. Mark A. Douglas as Chairman.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$151.00 – $203.00 (median $172.00) · 5 analysts · as of 2026-06-08
Roughly priced in line with peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
KWR Quaker Chemical Corporation | Above typical Show detailsSector percentile: 79 of 100 | fair | elevated |
SHW Sherwin-Williams | Above typical Show detailsSector percentile: 71 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 85 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 54 of 100 | — | moderate |
1 material management or governance event in the past 24 months, led by executive changes. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 54% for the rest of the cohort, n=272).
Not investment advice. As of 2026-06-12.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on achieving year-over-year revenue growth through new business wins and market expansion.
Improve gross profit margins through cost management and operational efficiencies.
Focus on enhancing cash flow from operations through improved operating performance and reduced cash outflows.
Why it matters: If gross margins decline, it signals that cost pressures are hurting profitability. This could impact future earnings.
Confirms:Q2 gross margins decline more than 2% compared to Q1 2026.
Disproves:Gross margins stabilize or improve compared to Q1 2026.
Why it matters: Positive cash flow shows Quaker Chemical is managing its operations well. This could support future investments.
Confirms:Cash flow from operations remains positive in Q2.
Disproves:Cash flow from operations turns negative in Q2.
Why it matters: Changes in leadership can affect how a company works and performs. Watching this can help understand its future.
Confirms one read:New chair outlines a clear strategy that aligns with revenue growth.
Confirms the other:If the new chair does not share a clear plan, it can create doubt.
Why it matters: Progress on this program can help make more money and improve cash flow. These are key goals for management.
Confirms:Management reports achieving at least $10 million in cost savings by the end of 2026.
Disproves:No significant updates or savings reported by the end of 2026.
Why it matters: Better revenue growth shows that Quaker Chemical is handling challenges in the sector. This may help investors feel more confident.
Confirms:Q2 revenue growth exceeds 1% year over year.
Disproves:Q2 revenue growth remains below 1% year over year.
Why it matters: Higher gross profit margins would show Quaker Chemical is managing costs better. This could lead to better earnings.
Confirms:Gross profit margin increases beyond 37% in Q2.
Disproves:Gross profit margin falls below 37% in Q2.
Why it matters: A decline in revenue growth would signal deeper issues in the market and could hurt investor confidence.
Confirms:Q2 revenue growth turns negative compared to Q1 2026.
Disproves:Q2 revenue growth remains positive compared to Q1 2026.
Results of Operations and Financial Condition. On April 30, 2026, Quaker Chemical Corporation announced its results of operations for the first quarter ended March 31, 2026 in a press release, the text of which is included as Exhibit 99.1 hereto. Supplemental information related to the same period is also included as Exhibit 99.2 hereto.